91. Budd-Chiari syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 5 - (DrugBank : 4) / Drug target genes : 4 - Drug target pathways : 14
Budd-Chiari syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 91 | Budd-Chiari syndrome | - |
| 88 | Chronic thromboembolic pulmonary hypertension | 2.423 |
| 85 | Idiopathic interstitial pneumonia | 2.273 |
| 49 | Systemic lupus erythematosus | 2.270 |
| 97 | Ulcerative colitis | 2.266 |
| 96 | Crohn disease | 2.263 |
| 46 | Malignant rheumatoid arthritis | 2.262 |
| 66 | IgA nephropathy | 1.057 |
| 19 | Lysosomal storage disease | 1.029 |
| 8 | Huntington disease | 1.024 |
| 86 | Pulmonary arterial hypertension | 1.020 |
| 6 | Parkinson disease | 1.011 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.008 |